These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8852407

  • 21. Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.
    Mizutani M, Iyori M, Blagborough AM, Fukumoto S, Funatsu T, Sinden RE, Yoshida S.
    Infect Immun; 2014 Oct; 82(10):4348-57. PubMed ID: 25092912
    [Abstract] [Full Text] [Related]

  • 22. Kinetics of expression of two major Plasmodium berghei antigens in the mosquito vector, Anopheles stephensi.
    Simonetti AB, Billingsley PF, Winger LA, Sinden RE.
    J Eukaryot Microbiol; 1993 Oct; 40(5):569-76. PubMed ID: 8401470
    [Abstract] [Full Text] [Related]

  • 23. The biosynthesis and post-translational modification of Pbs21 an ookinete-surface protein of Plasmodium berghei.
    Blanco AR, Paez A, Gerold P, Dearsly AL, Margos G, Schwarz RT, Barker G, Rodriguez MC, Sinden RE.
    Mol Biochem Parasitol; 1999 Jan 25; 98(2):163-73. PubMed ID: 10080386
    [Abstract] [Full Text] [Related]

  • 24. Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission.
    Blagborough AM, Yoshida S, Sattabongkot J, Tsuboi T, Sinden RE.
    Vaccine; 2010 Aug 23; 28(37):6014-20. PubMed ID: 20637303
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Expression, purification and antigenicity of Neospora caninum-antigens using silkworm larvae targeting for subunit vaccines.
    Otsuki T, Dong J, Kato T, Park EY.
    Vet Parasitol; 2013 Feb 18; 192(1-3):284-7. PubMed ID: 23102762
    [Abstract] [Full Text] [Related]

  • 28. The C-terminal region of the Plasmodium yoelii microgamete surface antigen PyMiGS induces potent anti-malarial transmission-blocking immunity in mice.
    Tachibana M, Baba M, Takashima E, Tsuboi T, Torii M, Ishino T.
    Vaccine; 2020 Mar 30; 38(15):3129-3136. PubMed ID: 32147299
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation of immunogenicity of an oral Salmonella vaccine expressing recombinant Plasmodium berghei merozoite surface protein-1.
    Toebe CS, Clements JD, Cardenas L, Jennings GJ, Wiser MF.
    Am J Trop Med Hyg; 1997 Feb 30; 56(2):192-9. PubMed ID: 9080880
    [Abstract] [Full Text] [Related]

  • 34. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T, Komesu A, Otsuki H, Sattabongkot J, Udomsangpetch R, Matsumoto Y, Tsuji N, Wu Y, Torii M, Tsuboi T.
    Infect Immun; 2005 Nov 30; 73(11):7375-80. PubMed ID: 16239536
    [Abstract] [Full Text] [Related]

  • 35. Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates.
    Lee SM, Wu CK, Plieskatt J, McAdams DH, Miura K, Ockenhouse C, King CR.
    Malar J; 2016 Aug 11; 15(1):405. PubMed ID: 27515826
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Malaria ookinete surface protein-based vaccination via the intranasal route completely blocks parasite transmission in both passive and active vaccination regimens in a rodent model of malaria infection.
    Arakawa T, Tachibana M, Miyata T, Harakuni T, Kohama H, Matsumoto Y, Tsuji N, Hisaeda H, Stowers A, Torii M, Tsuboi T.
    Infect Immun; 2009 Dec 11; 77(12):5496-500. PubMed ID: 19752035
    [Abstract] [Full Text] [Related]

  • 40. The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes.
    Tachibana M, Ishino T, Tsuboi T, Torii M.
    Vaccine; 2018 Nov 26; 36(49):7463-7471. PubMed ID: 30420038
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.